Browsing Category
Healthcare Industry News
2513 posts
Why Clean Simple Eats showing up in Walmart may be a bigger deal than it looks
Clean Simple Eats is now in 2,000 Walmart stores. Read why this retail expansion could reshape premium protein growth and shelf competition.
April 5, 2026
Why Folly’s pill-strength hair gummy launch could test a new model for beauty supplements
Folly has launched a pill-strength hair health gummy backed by Khosla Ventures. Find out what its biotech pitch means for supplements and beauty wellness.
April 5, 2026
Menoveda just added another U.S. store, but the bigger story is where menopause wellness is heading
Menoveda has entered Harvest Natural Foods in California as its U.S. retail rollout expands. Read what this means for menopause wellness growth.
April 5, 2026
LightStim and Hand & Stone roll out FDA-cleared Elipsa nationwide as LED facials go mainstream
LightStim and Hand & Stone are taking FDA-cleared Elipsa nationwide. Read how the rollout could reshape professional LED skincare access.
April 4, 2026
Why Korcomptenz and Hindsait think explainable AI is healthcare’s missing layer
Korcomptenz and Hindsait team up to deploy responsible AI in healthcare operations. Discover how this partnership could reshape efficiency and care delivery.
April 4, 2026
Vericel (VCEL) wins $197m BARDA contract to stockpile NexoBrid and build U.S. burn care supply chain
Vericel Corporation lands a ten-year $197M BARDA contract for NexoBrid procurement and U.S. manufacturing. Read why this changes the NexoBrid risk profile.
April 4, 2026
Nu Skin (NYSE: NUS) just launched an AI wellness scanner, but can Prysm iO actually change the company’s growth story?
Nu Skin Enterprises has launched Prysm iO in the U.S. Read how the device could reshape growth, retention, and investor sentiment around NYSE: NUS.
April 3, 2026
Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results
Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.
April 3, 2026
Co-Diagnostics (CODX) secures Saudi manufacturing land for CoMira JV as Gulf diagnostic localisation drive accelerates
Co-Diagnostics' CoMira joint venture secures Sudair Industrial City land for Saudi PCR manufacturing. Read what MODON approval means for CODX investors.
April 2, 2026
Caris Life Sciences (NASDAQ: CAI) says final Achieve 1 data strengthens the case for Caris Detect, but can MCED execution close the gap?
Caris Life Sciences says final Achieve 1 data strengthens Caris Detect. Read why the MCED opportunity looks bigger, and why execution risk still matters.
April 1, 2026